O-Desmethylquinidine is a major active metabolite of the antiarrhythmic drug quinidine. It is formed in the liver via the cytochrome P450 enzyme system, primarily CYP3A4. This compound retains significant pharmacological activity, contributing to the overall therapeutic and toxic effects observed during quinidine therapy. As a metabolite, O-desmethylquinidine is primarily used as a reference standard in pharmacokinetic and pharmacodynamic studies. It is crucial for analytical method development and validation in bioanalytical assays, enabling the accurate quantification of quinidine and its metabolites in biological samples (e.g., plasma, urine). This supports therapeutic drug monitoring, drug interaction studies, and research into quinidine's metabolism and disposition. The availability of O-desmethylquinidine as a well-characterized standard is essential for ensuring the safety and efficacy profile of quinidine, a Class IA antiarrhythmic agent used for the maintenance of normal sinus rhythm in patients with atrial fibrillation or flutter.